Sigyn Therapeutics Inc
(SIGY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 150 | 38 | 144 | 318 | 42 |
| Receivables | N/A | N/A | N/A | N/A | 26 |
| Inventories | 724 | 742 | 733 | 703 | 7 |
| TOTAL | $875 | $784 | $883 | $1,027 | $91 |
| Non-Current Assets | |||||
| PPE Net | 38 | 6 | 7 | 8 | 19 |
| Intangibles | 1,429 | 268 | 268 | 260 | 126 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 9 |
| TOTAL | $1,467 | $274 | $275 | $268 | $154 |
| Total Assets | $2,342 | $1,058 | $1,158 | $1,294 | $245 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,029 | N/A | N/A | N/A | 501 |
| Accounts payable and accrued liabilities | 32 | 399 | 399 | 397 | 577 |
| Accrued Expenses | 776 | 711 | 646 | 581 | N/A |
| Other current liabilities | 1,087 | 746 | 789 | 575 | 87 |
| TOTAL | $3,003 | $1,857 | $1,834 | $1,553 | $1,427 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 79 | N/A | N/A | N/A | 262 |
| Other Non-Current Liabilities | 31 | 444 | 299 | 156 | 0 |
| TOTAL | $31 | $444 | $299 | $156 | $N/A |
| Total Liabilities | $3,034 | $2,301 | $2,133 | $1,709 | $1,427 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7 | 6 | 6 | 6 | 6 |
| Common Shares | 4 | 3 | 3 | 3 | 0 |
| Retained earnings | -6,130 | -5,496 | -5,064 | -4,178 | -2,770 |
| TOTAL | $-692 | $-1,242 | $-975 | $-415 | $-1,181 |
| Total Liabilities And Equity | $2,342 | $1,058 | $1,158 | $1,294 | $245 |